Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study.
Bian D, Sun L, Hu J, Duan L, Xia H, Zhu X, Sun F, Zhang L, Yu H, Xiong Y, Huang Z, Zhao D, Song N, Yang J, Bao X, Wu W, Huang J, He W, Zhu Y, Jiang G, Zhang P.
Bian D, et al. Among authors: xiong y.
Nat Commun. 2023 Aug 3;14(1):4655. doi: 10.1038/s41467-023-40349-z.
Nat Commun. 2023.
PMID: 37537219
Free PMC article.
Clinical Trial.